Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-11 Sale |
2024-09-11 4:13 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
1,468 | $31.89 | $46,815 | 99,958 (Direct) |
View |
| 2024-09-11 Sale |
2024-09-11 4:13 pm |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
5,270 | $31.89 | $168,060 | 140,612 (Direct) |
View |
| 2024-09-06 Sale |
2024-09-10 4:05 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
126,074 | $32.15 | $4,052,851 | 190,368 (Direct) |
View |
| 2024-09-05 Sale |
2024-09-09 4:05 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
1,577 | $35.03 | $55,242 | 6,193,787 (Indirect) |
View |
| 2024-09-04 Purchase |
2024-09-04 5:42 pm |
Dyne Therapeutics Inc. | DYN | Cox John CEO & President |
32,000 | $33.04 | $1,057,216 | 13,000 (Indirect Direct) |
View |
| 2024-08-30 Sale |
2024-09-04 4:05 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
31,300 | $45.59 | $1,427,063 | 6,195,364 (Indirect) |
View |
| 2024-08-28 Sale |
2024-08-30 4:05 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
134,261 | $45.03 | $6,045,783 | 6,226,664 (Indirect) |
View |
| 2024-08-26 Sale |
2024-08-28 4:05 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
154,900 | $44.87 | $6,950,453 | 6,360,925 (Indirect) |
View |
| 2024-08-22 Sale |
2024-08-26 4:05 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
180,409 | $46.02 | $8,302,088 | 6,515,825 (Indirect) |
View |
| 2024-08-20 Sale |
2024-08-22 4:05 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
222,603 | $46.61 | $10,375,620 | 6,696,234 (Indirect) |
View |
| 2024-08-19 Sale |
2024-08-20 4:28 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
2,752 | $45.12 | $124,174 | 111,022 (Direct) |
View |
| 2024-08-19 Sale |
2024-08-20 4:27 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
2,705 | $45.12 | $122,054 | 132,106 (Direct) |
View |
| 2024-08-19 Sale |
2024-08-20 4:27 pm |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
2,321 | $45.12 | $104,727 | 143,222 (Direct) |
View |
| 2024-08-19 Sale |
2024-08-20 4:26 pm |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
2,910 | $45.12 | $131,304 | 145,882 (Direct) |
View |
| 2024-08-19 Sale |
2024-08-20 4:26 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
2,636 | $45.12 | $118,939 | 144,875 (Direct) |
View |
| 2024-08-16 Sale |
2024-08-20 4:05 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
248,675 | $45.48 | $11,310,183 | 6,918,837 (Indirect) |
View |
| 2024-08-14 Sale |
2024-08-16 4:05 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
281,541 | $44.76 | $12,601,536 | 7,167,512 (Indirect) |
View |
| 2024-08-12 Sale |
2024-08-14 4:15 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
212,477 | $42.93 | $9,121,902 | 7,449,053 (Indirect) |
View |
| 2024-08-08 Sale(A) |
2024-08-14 4:05 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
183,834 | $42.85 | $7,877,091 | 7,661,530 (Indirect) |
View |
| 2024-08-08 Sale |
2024-08-12 4:05 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
183,834 | $42.85 | $7,877,091 | 7,661,530 (Indirect) |
View |
| 2024-06-21 Sale(A) |
2024-07-03 9:00 pm |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
40,000 | $35.09 | $1,403,668 | 279,977 (Direct) |
View |
| 2024-06-21 Sale |
2024-06-24 8:41 pm |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
39,950 | $35.09 | $1,401,902 | 280,027 (Direct) |
View |
| 2024-06-12 Sale |
2024-06-13 9:45 pm |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
40,000 | $33.36 | $1,334,201 | 249,278 (Direct) |
View |
| 2024-06-11 Sale |
2024-06-11 7:42 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
2,136 | $31.34 | $66,942 | 147,511 (Direct) |
View |
| 2024-06-11 Sale |
2024-06-11 7:41 pm |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
2,636 | $31.27 | $82,428 | 145,543 (Direct) |
View |
| 2024-06-10 Sale |
2024-06-11 7:34 pm |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
85,270 | $30.3 | $2,583,782 | 289,278 (Direct) |
View |
| 2024-06-11 Sale |
2024-06-11 7:34 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
1,823 | $31.34 | $57,133 | 134,811 (Direct) |
View |
| 2024-06-10 Sale |
2024-06-11 7:28 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
2,921 | $30.74 | $89,779 | 113,774 (Direct) |
View |
| 2024-05-20 Sale |
2024-05-22 9:01 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
30,426 | $32.96 | $1,002,751 | 149,647 (Direct) |
View |
| 2024-05-16 Sale |
2024-05-17 9:07 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
2,705 | $28.27 | $76,469 | 149,647 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-09-06 Exercise |
2024-09-10 4:05 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
9,855 | $5.54 | 190,368 (Direct) |
View |
| 2024-09-06 Exercise |
2024-09-10 4:05 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
34,833 | $19 | 190,368 (Direct) |
View |
| 2024-09-06 Exercise |
2024-09-10 4:05 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
29,792 | $8.58 | 190,368 (Direct) |
View |
| 2024-09-06 Exercise |
2024-09-10 4:05 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
116,478 | $0 | 190,368 (Direct) |
View |
| 2024-09-06 Exercise |
2024-09-10 4:05 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
6,552 | $10.88 | 190,368 (Direct) |
View |
| 2024-09-06 Exercise |
2024-09-10 4:05 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
16,696 | $13.12 | 190,368 (Direct) |
View |
| 2024-09-06 Exercise |
2024-09-10 4:05 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
18,750 | $10.72 | 190,368 (Direct) |
View |
| 2024-09-03 Option Award |
2024-09-03 6:22 pm |
N/A 2034-09-02 |
Dyne Therapeutics Inc. | DYN | Kerr Douglas Chief Medical Officer |
197,800 | $0 | 197,800 (Direct) |
View |
| 2024-09-03 Option Award |
2024-09-03 6:16 pm |
N/A 2034-09-02 |
Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer |
243,700 | $0 | 243,700 (Direct) |
View |
| 2024-06-21 Exercise(A) |
2024-07-03 9:00 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
40,000 | $5.54 | 279,977 (Direct) |
View |
| 2024-06-21 Exercise(A) |
2024-07-03 9:00 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
40,000 | $0 | 279,977 (Direct) |
View |
| 2024-06-21 Exercise |
2024-06-24 8:41 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
39,950 | $5.54 | 280,027 (Direct) |
View |
| 2024-06-21 Exercise |
2024-06-24 8:41 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
39,950 | $0 | 280,027 (Direct) |
View |
| 2024-06-12 Exercise |
2024-06-13 9:45 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
40,000 | $5.54 | 249,278 (Direct) |
View |
| 2024-06-12 Exercise |
2024-06-13 9:45 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
40,000 | $0 | 249,278 (Direct) |
View |
| 2024-06-10 Exercise |
2024-06-11 7:34 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
80,000 | $5.54 | 289,278 (Direct) |
View |
| 2024-06-10 Exercise |
2024-06-11 7:34 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
80,000 | $0 | 289,278 (Direct) |
View |
| 2024-05-22 Option Award |
2024-05-24 5:10 pm |
N/A 2034-05-21 |
Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director |
25,133 | $0 | 25,133 (Direct) |
View |
| 2024-05-22 Option Award |
2024-05-24 5:10 pm |
N/A 2034-05-21 |
Dyne Therapeutics Inc. | DYN | Incerti Carlo Director |
25,133 | $0 | 25,133 (Direct) |
View |
| 2024-05-22 Option Award |
2024-05-24 5:10 pm |
N/A 2034-05-21 |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
25,133 | $0 | 25,133 (Direct) |
View |
| 2024-05-22 Option Award |
2024-05-24 5:10 pm |
N/A 2034-05-21 |
Dyne Therapeutics Inc. | DYN | HURWITZ EDWARD Director |
25,133 | $0 | 25,133 (Direct) |
View |
| 2024-05-22 Option Award |
2024-05-24 5:10 pm |
N/A 2034-05-21 |
Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director |
25,133 | $0 | 25,133 (Direct) |
View |
| 2024-05-22 Option Award |
2024-05-24 5:10 pm |
N/A 2034-05-21 |
Dyne Therapeutics Inc. | DYN | Lubner David Charles Director |
25,133 | $0 | 25,133 (Direct) |
View |
| 2024-05-20 Exercise |
2024-05-22 9:01 pm |
N/A 2030-01-05 |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
30,426 | $0 | 149,647 (Direct) |
View |
| 2024-05-20 Exercise |
2024-05-22 9:01 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
30,426 | $1.03 | 149,647 (Direct) |
View |